Biopharmaceutical Company Huanuotai Completes Angel Round of Financing

According to PEdaily.cn, Beijing Huanuotai Biopharmaceutical Technology Co., Ltd. ("Huanuotai") has obtained the angel round investment from Moom Group. Huanuotai focuses on the development of innovative vaccines and adjuvants and the upgrading of vaccine products in China.

Huanotai owns advanced technologies, such as adjuvant technology, carrier technology and antigen screening technology, among which the adjuvant technology is going to play an important role in the Chinese vaccine field. The research team of Huanotai has been deeply engaged in the field of biomedicine for many years, covering all processes of the pre-clinical development of drugs, including drug discovery, pilot test, validation, degradation studies, and toxicology research.

Wu Jiafu, chairman of Moom Group, said, "The investment will help to expand our business in the biomedical field, including vaccines, antibodies, diagnostic reagents, rapid detection, and other segments. Previously we have invested in IntelliBio, Hezong Medicine, Zensun and other well-known companies in order to build an industry chain in healthcare. With the support of capital, those pharmaceutical enterprises can grow rapidly and launch the products to the market as soon as possible to meet the clinical needs, especially in the prevention and treatment of major infectious diseases."

In the short term, the sudden outbreak of COVID-19 has increased the demand for household medical devices such as thermometers, low-value supplies such as masks and gloves, antiviral drugs and medical devices such as monitors. From a medium to long-term perspective, society will invest more in the field of medical and healthcare, and the industry is expected to benefit in a long time.

Founded in 2005 and headquartered in Beijing, Moom Group is an industrial financial service group focusing on intelligent technology. The group has branches in Xiamen, Nanjing, Chengdu, Anxi, Fuzhou, Hangzhou, Nanjing, Tianjin, Dalian and other places. The assets under management of Moom Group is nearly 17 billion yuan.